Detalles de la búsqueda
1.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37290468
2.
First-Line Immunochemotherapy Versus Palliative Chemotherapy Plus Definitive Radiation Therapy for de novo Metastatic Nasopharyngeal Carcinoma: A Matched Cohort Study.
Cancer Control
; 29: 10732748221124868, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36047451
3.
Determining the suitability of definitive radiation therapy in patients with metastatic nasopharyngeal carcinoma based on PET/CT: a large cohort study.
Eur Radiol
; 32(11): 7722-7732, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35505116
4.
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
BMC Cancer
; 20(1): 89, 2020 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32013967
5.
Liposomal paclitaxel versus docetaxel in induction chemotherapy using Taxanes, cisplatin and 5-fluorouracil for locally advanced nasopharyngeal carcinoma.
BMC Cancer
; 18(1): 1279, 2018 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-30572856
6.
Prognostic value of metastatic cervical lymph node stiffness in nasopharyngeal carcinoma: A prospective cohort study.
Radiother Oncol
; 189: 109939, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37806561
7.
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.
Eur J Cancer
; 194: 113336, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801967
8.
Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study.
Head Neck
; 44(5): 1057-1068, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35146832
9.
Management of first-line palliative chemotherapy for post-treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non-gemcitabine plus cisplatin chemotherapy.
Head Neck
; 44(1): 113-121, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716739
10.
The Prognostic Role of Plasma Epstein-Barr Virus DNA Levels in the Middle of Intensity Modulated Radiation Therapy to Guide Cisplatin Dose Recommendation in Concurrent Chemoradiation Therapy in Patients With Locally Advanced Nasopharyngeal Carcinoma: A Large Cohort Study.
Adv Radiat Oncol
; 7(3): 100908, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35647403
11.
Cost-Effectiveness analysis of combining plasma Epstein-Barr virus DNA testing and different surveillance imaging modalities for nasopharyngeal carcinoma patients in first remission.
Oral Oncol
; 128: 105851, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35430526
12.
Impact of salvage radiotherapy on survival of patients with advanced locally recurrent nasopharyngeal carcinoma: Derivation and validation of a predictive model.
Radiother Oncol
; 167: 252-260, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34998900
13.
Deintensified Chemoradiotherapy for Pretreatment Epstein-Barr Virus DNA-Selected Low-Risk Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase II Randomized Noninferiority Trial.
J Clin Oncol
; 40(11): 1163-1173, 2022 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34990291
14.
Alpha-fetoprotein-producing recurrent nasopharyngeal carcinoma: A case report.
SAGE Open Med Case Rep
; 9: 2050313X211057704, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34777811
15.
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
Radiother Oncol
; 160: 9-17, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33839205
16.
Establishment and validation of a prognostic nomogram to predict early metastasis in nasopharyngeal carcinoma patients within six months after radiotherapy and to guide intensive treatment.
Radiother Oncol
; 162: 202-211, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33839207
17.
Effect of Concurrent Chemoradiotherapy With Nedaplatin vs Cisplatin on the Long-term Outcomes of Survival and Toxic Effects Among Patients With Stage II to IVB Nasopharyngeal Carcinoma: A 5-Year Follow-up Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 4(12): e2138470, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34928359
18.
Induction chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in the treatment of different risk locoregionally advanced nasopharyngeal carcinoma.
Ther Adv Med Oncol
; 12: 1758835920928214, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32536983
19.
Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients.
Oral Oncol
; 92: 40-45, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31010621
20.
The impact of Adult Comorbidity Evaluation-27 on the clinical outcome of elderly nasopharyngeal carcinoma patients treated with chemoradiotherapy or radiotherapy: a matched cohort analysis.
J Cancer
; 10(23): 5614-5621, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31737097